218 related articles for article (PubMed ID: 15858090)
1. MR-guided percutaneous intramyocardial injection with an MR-compatible catheter: feasibility and changes in T1 values after injection of extracellular contrast medium in pigs.
Krombach GA; Pfeffer JG; Kinzel S; Katoh M; Günther RW; Buecker A
Radiology; 2005 May; 235(2):487-94. PubMed ID: 15858090
[TBL] [Abstract][Full Text] [Related]
2. Transendocardial delivery of extracellular myocardial markers by using combination X-ray/MR fluoroscopic guidance: feasibility study in dogs.
Saeed M; Lee R; Martin A; Weber O; Krombach GA; Schalla S; Lee M; Saloner D; Higgins CB
Radiology; 2004 Jun; 231(3):689-96. PubMed ID: 15163809
[TBL] [Abstract][Full Text] [Related]
3. MR guidance of targeted injections into border and core of scarred myocardium in pigs.
Saeed M; Martin AJ; Lee RJ; Weber O; Revel D; Saloner D; Higgins CB
Radiology; 2006 Aug; 240(2):419-26. PubMed ID: 16801371
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance-guided angioplasty with delivery of contrast-media doped solutions to the vessel wall: an experimental study in swine.
Krombach GA; Wehner M; Perez-Bouza A; Kaimann L; Kinzel S; Plum T; Schibur D; Friebe M; Günther RW; Hohl C
Invest Radiol; 2008 Jul; 43(7):530-7. PubMed ID: 18580336
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
7. Comparison study of intraarticular and intravenous gadolinium-enhanced magnetic resonance imaging of cartilage in a canine model.
Kwack KS; Cho JH; Kim M MS; Yoon CS; Yoon YS; Choi JW; Kwon JW; Min BH; Sun JS; Kim SY
Acta Radiol; 2008 Feb; 49(1):65-74. PubMed ID: 17963083
[TBL] [Abstract][Full Text] [Related]
8. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
[TBL] [Abstract][Full Text] [Related]
9. Distribution of intramyocardially injected extracellular MR contrast medium: effects of concentration and volume.
Krombach GA; Baireuther R; Higgins CB; Saeed M
Eur Radiol; 2004 Feb; 14(2):334-40. PubMed ID: 14618368
[TBL] [Abstract][Full Text] [Related]
10. Determination of optimal gadolinium concentration using SSFP for catheter-directed contrast-enhanced coronary MR angiography.
Schirf BE; Green JD; Sato K; Larson AC; Shaibani A; Salem R; Li D; Omary RA
Acad Radiol; 2005 Jun; 12(6):771-5. PubMed ID: 15935975
[TBL] [Abstract][Full Text] [Related]
11. Fast magnetization-driven preparation for imaging of contrast-enhanced coronary arteries during intra-arterial injection of contrast agent.
Gui D; Tsekos NV
J Magn Reson Imaging; 2006 Nov; 24(5):1151-8. PubMed ID: 17031833
[TBL] [Abstract][Full Text] [Related]
12. Cardiac MRI: estimation of changes in normalized myocardial gadolinium accumulation over time after contrast injection in patients with acute myocarditis and healthy volunteers.
Breuckmann F; Maderwald S; Buhr C; Bruder O; Schlosser T; Erbel R; Barkhausen J; Nassenstein K
Rofo; 2011 Oct; 183(10):933-8. PubMed ID: 21863535
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
15. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction.
Klein C; Schmal TR; Nekolla SG; Schnackenburg B; Fleck E; Nagel E
J Cardiovasc Magn Reson; 2007; 9(4):653-8. PubMed ID: 17578720
[TBL] [Abstract][Full Text] [Related]
17. Contrast-dose relation in first-pass myocardial MR perfusion imaging.
Utz W; Niendorf T; Wassmuth R; Messroghli D; Dietz R; Schulz-Menger J
J Magn Reson Imaging; 2007 Jun; 25(6):1131-5. PubMed ID: 17520736
[TBL] [Abstract][Full Text] [Related]
18. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
[TBL] [Abstract][Full Text] [Related]
20. MR imaging of the lymphatic system: distribution and contrast enhancement of gadodiamide after intradermal injection.
Lohrmann C; Földi E; Bartholomä JP; Langer M
Lymphology; 2006 Dec; 39(4):156-63. PubMed ID: 17319626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
